Brief: DBP International Q2 Operating Loss Widens To SEK 2.8 Mln
27/08/2020 08:07
Aug 27 (Reuters) - Double Bond Pharmaceutical International
AB DBPHAb.TE :
* SAID ON WEDNESDAY Q2 TOTAL REVENUES AT SEK 0.3 MLN VS SEK
1.0
MLN YR AGO
* Q2 OPERATING LOSS SEK 2.8 MLN VS LOSS SEK 2.6 MLN YR AGO
Source text for Eikon: urn:newsml:reuters.com:*:nWkr6bdlT4
Further company coverage: DBPHAb.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University